Variant report

Variant	esv3439309
Chromosome Location	chr6:5084978-5087526
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:163)
CpG islands
(count:735)
Chromatin interactive
region (count:4)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:163 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr6:5085023-5085434	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr6:5086627-5086879	H1-hESC	embryonic stem cell:	n/a	n/a
3	BHLHE40	chr6:5084524-5085406	GM12878	blood:	n/a	chr6:5084890-5084906 chr6:5084923-5084939 chr6:5084823-5084839
4	BHLHE40	chr6:5085096-5085291	K562	blood:	n/a	n/a
5	CHD2	chr6:5085579-5085595	Hela-S3	cervix:	n/a	n/a
6	CHD2	chr6:5086078-5086932	H1-hESC	embryonic stem cell:	n/a	n/a
7	CHD2	chr6:5085994-5086022	GM12878	blood:	n/a	n/a
8	CHD2	chr6:5085119-5085264	HepG2	liver:	n/a	n/a
9	CHD2	chr6:5084520-5085350	GM12878	blood:	n/a	n/a
10	CTBP2	chr6:5084541-5085419	H1-hESC	embryonic stem cell:	n/a	n/a
11	CTCF	chr6:5085480-5085630	GM12871	blood:	n/a	n/a
12	CTCF	chr6:5085145-5085354	GM12878	blood:	n/a	n/a
13	CTCF	chr6:5085040-5085190	GM12867	blood:	n/a	n/a
14	CTCF	chr6:5084940-5085090	GM12865	blood:	n/a	n/a
15	CTCF	chr6:5086000-5086150	GM12869	blood:	n/a	n/a
16	CTCF	chr6:5085320-5085470	WERI-Rb-1	eye:	n/a	n/a
17	CTCF	chr6:5085200-5085350	GM12871	blood:	n/a	n/a
18	CTCF	chr6:5085100-5085250	GM12864	blood:	n/a	n/a
19	CTCF	chr6:5085940-5086090	GM12865	blood:	n/a	n/a
20	CTCF	chr6:5085020-5085170	GM06990	blood:	n/a	n/a
21	CTCF	chr6:5086260-5086410	WERI-Rb-1	eye:	n/a	n/a
22	CTCF	chr6:5085460-5085610	AG04449	skin:	n/a	n/a
23	CTCF	chr6:5086465-5086503	GM13976	blood:	n/a	n/a
24	CTCF	chr6:5085120-5085270	GM12873	blood:	n/a	n/a
25	CTCF	chr6:5085080-5085230	HCFaa	heart:	n/a	n/a
26	CTCF	chr6:5085040-5085190	HCM	heart:	n/a	n/a
27	CTCF	chr6:5085280-5085430	GM12875	blood:	n/a	n/a
28	CTCF	chr6:5085920-5086070	AG04449	skin:	n/a	n/a
29	CTCF	chr6:5085240-5085390	WERI-Rb-1	eye:	n/a	n/a
30	CTCF	chr6:5086720-5086870	AG04449	skin:	n/a	n/a
31	CTCF	chr6:5085400-5085550	WERI-Rb-1	eye:	n/a	n/a
32	CTCF	chr6:5086706-5086838	GM19238	blood:	n/a	n/a
33	CTCF	chr6:5085340-5085490	NHLF	lung:	n/a	n/a
34	CTCF	chr6:5085120-5085270	GM12865	blood:	n/a	n/a
35	CTCF	chr6:5084980-5085130	HUVEC	blood vessel:	n/a	n/a
36	CTCF	chr6:5085140-5085290	GM12874	blood:	n/a	n/a
37	CTCF	chr6:5085276-5085282	GM19240	blood:	n/a	n/a
38	CTCF	chr6:5086640-5086790	AG04449	skin:	n/a	n/a
39	CTCF	chr6:5085180-5085330	HCPEpiC	choroid plexus:	n/a	n/a
40	CTCF	chr6:5084960-5085110	GM12875	blood:	n/a	n/a
41	CTCF	chr6:5085240-5085390	GM12864	blood:	n/a	n/a
42	CTCF	chr6:5085320-5085470	AG09319	gingival:	n/a	n/a
43	CTCF	chr6:5085148-5085243	GM19240	blood:	n/a	n/a
44	E2F6	chr6:5084457-5085372	K562	blood:	n/a	chr6:5085074-5085089 chr6:5085073-5085082 chr6:5084902-5084911 chr6:5084924-5084934
45	E2F6	chr6:5086779-5086916	K562	blood:	n/a	n/a
46	E2F6	chr6:5085749-5087127	H1-hESC	embryonic stem cell:	n/a	n/a
47	E2F6	chr6:5084844-5087368	H1-hESC	embryonic stem cell:	n/a	chr6:5085074-5085089 chr6:5085073-5085082 chr6:5084902-5084911 chr6:5084924-5084934
48	E2F6	chr6:5085785-5086331	A549	lung:	n/a	n/a
49	EBF1	chr6:5085926-5086150	GM12878	blood:	n/a	n/a
50	EBF1	chr6:5084553-5085203	GM12878	blood:	n/a	n/a

(count:735 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:5087266-5087316	BE2_C	brain:	n/a
2	chr6:5086610-5086660	HNPCEpiC	eye:	n/a
3	chr6:5085597-5085647	BE2_C	brain:	n/a
4	chr6:5087266-5087316	BE2_C	brain:	n/a
5	chr6:5086610-5086660	HNPCEpiC	eye:	n/a
6	chr6:5085597-5085647	BE2_C	brain:	n/a
7	chr6:5085177-5085227	MCF10A-Er-Src	breast:	n/a
8	chr6:5085709-5085759	HAEpiC	amniotic membrane:	n/a
9	chr6:5085709-5085759	GM06990	blood:	n/a
10	chr6:5085986-5086036	H1-hESC	embryonic stem cell:	embryo
11	chr6:5087266-5087316	RPTEC	kidney:	n/a
12	chr6:5086036-5086086	SKMC	muscle:	n/a
13	chr6:5087447-5087497	HL-60	blood:	n/a
14	chr6:5087266-5087316	HepG2	liver:	n/a
15	chr6:5085586-5085636	BJ	skin:	n/a
16	chr6:5085586-5085636	HNPCEpiC	eye:	n/a
17	chr6:5085177-5085227	BE2_C	brain:	n/a
18	chr6:5085586-5085636	GM06990	blood:	n/a
19	chr6:5085586-5085636	T-47D	breast:	n/a
20	chr6:5086610-5086660	HCT-116	colon:	n/a
21	chr6:5085713-5085763	HEK293	kidney:	embryo
22	chr6:5087266-5087316	Jurkat	blood:	n/a
23	chr6:5085404-5085454	BE2_C	brain:	n/a
24	chr6:5086036-5086086	AG04449	skin:	fetal
25	chr6:5087031-5087081	PANC-1	pancreas:	n/a
26	chr6:5086036-5086086	CMK	blood:	n/a
27	chr6:5085597-5085647	HEEpiC	esophagus:	n/a
28	chr6:5085586-5085636	PFSK-1	brain:	n/a
29	chr6:5086610-5086660	NH-A	brain:	n/a
30	chr6:5087266-5087316	NH-A	brain:	n/a
31	chr6:5087266-5087316	K562	blood:	n/a
32	chr6:5086036-5086086	H1-hESC	embryonic stem cell:	embryo
33	chr6:5085597-5085647	SK-N-MC	brain:	n/a
34	chr6:5085586-5085636	RPTEC	kidney:	n/a
35	chr6:5087266-5087316	ECC-1	luminal epithelium:	n/a
36	chr6:5085986-5086036	GM12878	blood:	n/a
37	chr6:5085709-5085759	NHDF-neo	bronchial:	n/a
38	chr6:5087447-5087497	PANC-1	pancreas:	n/a
39	chr6:5087447-5087497	PrEC	prostate:	n/a
40	chr6:5087266-5087316	AG04450	lung:	fetal
41	chr6:5085709-5085759	AG04449	skin:	fetal
42	chr6:5085597-5085647	GM12891	blood:	n/a
43	chr6:5085586-5085636	K562	blood:	n/a
44	chr6:5085713-5085763	AoSMC	blood vessel:	n/a
45	chr6:5087031-5087081	MCF10A-Er-Src	breast:	n/a
46	chr6:5085586-5085636	HRPEpiC	eye:	n/a
47	chr6:5085597-5085647	AG09319	gingival:	n/a
48	chr6:5085177-5085227	GM12878	blood:	n/a
49	chr6:5087031-5087081	Hepatocyte	liver:	n/a
50	chr6:5087266-5087316	HNPCEpiC	eye:	n/a

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:5079080..5082683-chr6:5086665..5090602,4	K562	blood:
2	chr6:5083037..5085353-chr6:5088863..5093171,5	MCF-7	breast:
3	chr6:5082094..5085573-chr6:5086074..5088451,3	K562	blood:
4	chr6:5082094..5085573-chr6:5086074..5088451,3	K562	blood:

No data

Variant related genes	Relation type
PPP1R3G	TF binding region
PPP1R3G	CpG island

Extended variants
information (count: 107 )
Associated
traits (count: 99 )

Variant overlapped rSNPs/rCNVs (count:107 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs577165978	chr6:5084985-5084986	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs541332181	chr6:5085002-5085003	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs553334538	chr6:5085017-5085018	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs574763407	chr6:5085042-5085043	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs541877059	chr6:5085089-5085090	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs563775385	chr6:5085119-5085120	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs530912552	chr6:5085173-5085174	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs546338649	chr6:5085185-5085186	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
9	rs143248584	chr6:5085188-5085189	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
10	rs578031441	chr6:5085191-5085192	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
11	rs185073703	chr6:5085199-5085200	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
12	rs2235844	chr6:5085203-5085204	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
13	rs75659241	chr6:5085227-5085228	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
14	rs34696933	chr6:5085243-5085244	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs569684268	chr6:5085244-5085245	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs536754506	chr6:5085248-5085249	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs558734434	chr6:5085289-5085290	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs570641615	chr6:5085327-5085328	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs534851827	chr6:5085339-5085340	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs73359253	chr6:5085364-5085365	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs560357922	chr6:5085373-5085374	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs200858	chr6:5085388-5085389	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs557088143	chr6:5085460-5085461	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs111883550	chr6:5085486-5085487	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs575636456	chr6:5085497-5085498	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs78511208	chr6:5085544-5085545	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs545889284	chr6:5085604-5085605	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
28	rs374531884	chr6:5085607-5085608	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
29	rs377376562	chr6:5085625-5085626	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
30	rs564266830	chr6:5085694-5085695	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs34209281	chr6:5085715-5085716	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs540441961	chr6:5085738-5085739	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs562375020	chr6:5085764-5085765	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs529560733	chr6:5085827-5085828	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs190012458	chr6:5085840-5085841	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs569538320	chr6:5085859-5085860	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs530557108	chr6:5085890-5085891	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs552288562	chr6:5085894-5085895	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs570579669	chr6:5085914-5085915	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs111286900	chr6:5085953-5085954	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs148308290	chr6:5085983-5085984	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs568304972	chr6:5086003-5086004	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs61752357	chr6:5086004-5086005	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs557270606	chr6:5086034-5086035	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs569838301	chr6:5086054-5086055	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs667752	chr6:5086070-5086071	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs34969826	chr6:5086072-5086073	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs557796150	chr6:5086095-5086096	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs573019621	chr6:5086152-5086153	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs540378356	chr6:5086189-5086190	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:99)

Disease	PMID	Source
Developmental delay	19490664	CNVD
Cancer	21183584	CNVD
Multiple Epiphyseal Dysplasia	20877625	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Glaucoma	18694899	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	16573809	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	17603634	CNVD
Cancer	20164920	CNVD
Colorectal cancer	21297112	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Myelodysplastic syndrome	21251322	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Bladder cancer	21909424	CNVD
Multiple myeloma	17550852	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	21364760	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Gastric cancer	16891809	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Autism	21448237	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
small cell lung cancer	20016488	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
dysmorphism	22105932	CNVD
psychomotor delay	22105932	CNVD
Ovarian cancer	19193619	CNVD
Osteosarcoma	16790693	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Amyotrophic lateral sclerosis	20685689	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:377 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:5080400-5085400	Flanking Active TSS	HepG2	liver
2	chr6:5083800-5085000	Bivalent/Poised TSS	Skeletal Muscle Male	skeletal muscle
3	chr6:5084200-5085000	Active TSS	Adipose Nuclei	Adipose
4	chr6:5084200-5085000	Bivalent/Poised TSS	Fetal Stomach	stomach
5	chr6:5084200-5085200	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
6	chr6:5084200-5086000	Active TSS	Right Ventricle	heart
7	chr6:5084200-5087400	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
8	chr6:5084400-5085000	Bivalent/Poised TSS	H9 Derived Neuron Cultured Cells	ES cell derived
9	chr6:5084400-5085000	Active TSS	Breast Myoepithelial Primary Cells	Breast
10	chr6:5084400-5085000	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
11	chr6:5084400-5085000	Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
12	chr6:5084400-5085000	Active TSS	Brain Hippocampus Middle	brain
13	chr6:5084400-5085000	Bivalent/Poised TSS	Fetal Intestine Large	intestine
14	chr6:5084400-5085000	Bivalent/Poised TSS	Fetal Muscle Leg	muscle
15	chr6:5084400-5085000	Bivalent Enhancer	Fetal Thymus	thymus
16	chr6:5084400-5085000	Active TSS	Skeletal Muscle Female	skeletal muscle
17	chr6:5084400-5085000	Active TSS	HUVEC	blood vessel
18	chr6:5084400-5085000	Active TSS	Osteobl	bone
19	chr6:5084400-5085200	Active TSS	HSMM	muscle
20	chr6:5084400-5085400	Flanking Active TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
21	chr6:5084400-5085400	Bivalent/Poised TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
22	chr6:5084400-5085400	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
23	chr6:5084400-5085400	Bivalent/Poised TSS	Colonic Mucosa	Colon
24	chr6:5084400-5085400	Flanking Active TSS	Placenta Amnion	Placenta Amnion
25	chr6:5084400-5085600	Active TSS	Rectal Mucosa Donor 29	rectum
26	chr6:5084400-5085600	Bivalent/Poised TSS	Spleen	Spleen
27	chr6:5084400-5085800	Bivalent/Poised TSS	iPS DF 6.9 Cell Line	embryonic stem cell
28	chr6:5084400-5085800	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
29	chr6:5084400-5085800	Active TSS	Fetal Kidney	kidney
30	chr6:5084400-5086000	Active TSS	Liver	Liver
31	chr6:5084400-5086000	Bivalent/Poised TSS	Fetal Brain Female	brain
32	chr6:5084400-5086200	Active TSS	A549	lung
33	chr6:5084400-5086400	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
34	chr6:5084400-5086400	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
35	chr6:5084400-5086400	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
36	chr6:5084400-5086400	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
37	chr6:5084400-5086400	Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
38	chr6:5084400-5086400	Flanking Active TSS	Cortex derived primary cultured neurospheres	brain
39	chr6:5084400-5086400	Active TSS	Brain Angular Gyrus	brain
40	chr6:5084400-5086400	Active TSS	Brain Cingulate Gyrus	brain
41	chr6:5084400-5086400	Active TSS	Brain Inferior Temporal Lobe	brain
42	chr6:5084400-5086400	Active TSS	Duodenum Smooth Muscle	Duodenum
43	chr6:5084400-5086400	Active TSS	Left Ventricle	heart
44	chr6:5084400-5086400	Active TSS	Rectal Mucosa Donor 31	rectum
45	chr6:5084400-5086400	Active TSS	Right Atrium	heart
46	chr6:5084400-5086600	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
47	chr6:5084400-5086600	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
48	chr6:5084400-5086600	Bivalent/Poised TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
49	chr6:5084400-5086600	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
50	chr6:5084400-5086600	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links